Limited-Time September Offer: Try 7 Days for Free

Sarepta Therapeutics (SRPT) Stock Price

$17.39 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    5
  • Fundamental

    1
  • Technical

    3

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Sarepta Therapeutics, AI stock picks, stock alerts and much more.

Sign up

SRPT AI Stock Analysis

AI stock analysis for SRPT is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sarepta Therapeutics (SRPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Sarepta Therapeutics (SRPT) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sarepta Therapeutics (SRPT), currently trading at $17.39, will... Sign up to access price prediction.

About SRPT

LSE
  • Sarepta Therapeutics, Inc.

  • Symbol

    SRPT

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.7B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$19.97
1.4%
8
INO Inovio Pharmaceuticals
INO
$2.38
10.2%
2
MRNA Moderna
MRNA
$23.51
7.4%
4
AVXL Anavex Life Sciences
AVXL
$9.37
2.2%
5
BBIO BridgeBio Pharma
BBIO
$51.21
2.6%
6

SRPT Alternative Data

Web Traffic

Sarepta Therapeutics receives an estimated 101247 monthly visitors to sarepta.com, which is down by -33.6% over the last month.

  • Web Traffic

    101247

  • Change from Previous Month

    33.6%

  • 3 Month Change

    78.2%

  • YoY Change

    78.2%

Twitter Followers

Sarepta Therapeutics has 6,366 Twitter Followers on its main Twitter (also known as X) account, which is up by 1% over the last month.

  • Twitter Followers

    6366

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    7.9%

  • YoY Change

    7.9%

Facebook Engagement

Sarepta Therapeutics has engaged 741 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    741

  • Daily Change

    0.5%

  • 1 Month Change

    63.7%

  • 3 Month Change

    20.7%

  • YoY Change

    20.7%

Instagram Followers

Sarepta Therapeutics has 5,740 Instagram Followers on its main Instagram account, up by 0.4% over the last month.

  • Instagram Followers

    5740

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    3.7%

  • YoY Change

    3.7%

LinkedIn Followers

128,499 are following Sarepta Therapeutics on LinkedIn, up by 1.2% over the last month.

  • LinkedIn Followers

    128499

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.9%

  • YoY Change

    3.9%

Job Postings

Sarepta Therapeutics currenly has an estimated 11 open job postings, up by 57.1% over the last month.

  • Job Postings

    11

  • Daily Change

    0%

  • 1 Month Change

    57.1%

  • 3 Month Change

    59.3%

  • YoY Change

    59.3%

LinkedIn Employees

According to LinkedIn, Sarepta Therapeutics has 1,294 employees, down by -4.6% over the last month.

  • LinkedIn Employees

    1294

  • Daily Change

    1.1%

  • 1 Month Change

    4.6%

  • 3 Month Change

    17.1%

  • YoY Change

    17.1%

Reddit Mentions

Sarepta Therapeutics has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    2

  • Daily Change

    0%

  • 1 Month Change

    60%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Sarepta Therapeutics is 39 out of 100 (bearish), down by -26.4% over the last month.

  • Business Outlook

    39

  • Change from Previous Month

    26.4%

  • 3 Month Change

    47.3%

  • YoY Change

    47.3%

Reddit Sentiment

The sentiment Score for Sarepta Therapeutics is 75 out of 100, which represents a bullish sentiment.

  • Reddit Sentiment

    75.4286

  • Daily Change

    29.3%

  • 1 Month Change

    29.3%

News Mentions

Sarepta Therapeutics was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

SRPT Financials

SRPT Key Metrics
  • Total Revenue

    $658.4M

  • Net Income

    $159M

  • Earnings per Share

    $1.65

  • Free cash flow

    $54M

  • EBITDA

    $161.7M

  • EBITDA Ratio

    0.245562

  • Total Assets

    $4B

SRPT 2-year Revenue & Income
SRPT 2-year Free Cash Flow

SRPT Technicals

SRPT SMA
SRPT RSI

FAQ

What's the current price of Sarepta Therapeutics (SRPT) Stock?
The price of an Sarepta Therapeutics (SRPT) share is $17.39.

What's the market cap of Sarepta Therapeutics?
The current market cap of Sarepta Therapeutics is 1.7B.

What are some stocks similar to Sarepta Therapeutics (SRPT) that investors often compare it to?
Sarepta Therapeutics (SRPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Sarepta Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sarepta Therapeutics' stock price to be around $16.65 in 2026. Starting from the current price of $17.39, this represents a 4.3% change in price, indicating a bearish outlook for the stock.

How to buy Sarepta Therapeutics (SRPT) Stock?
Sarepta Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sarepta Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.